Gates Foundation

Activity from announced rounds

Activity in this selectionOct 18, 2026 · Jul 21, 2026
Rounds participated in
2
Confirmed lead rounds
0
1 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$35M
1 disclosed · full round size, not this investor’s share

By stage

Undisclosed2

By primary sector

Biotech1
Healthtech1

By country

Sweden1
United States1

Rounds

2 in this selection
Readily Diagnostics

Readily Diagnostics develops molecular tests that help clinicians identify infectious diseases near the patient without relying on a central laboratory.

~$970KGates Foundation grant
Participant
ProFound Therapeutics

Uses AI and proteomics to discover drug targets and biomarkers for preeclampsia and eclampsia

$35MStrategic
Role not disclosed